Skip to main content
  • Should FDA Overlook Evidence Gaps for Life-Saving Devices? Clinicians argue the balance between patient needs and evidence base

    The creation of an FDA program to finalize the classification of high-risk devices that are already in widespread use has left clinicians arguing whether the bar should be raised on the evidence required for approval.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details